Servier hit by bone drug safety issues as Mediator continues to make waves
14 September 2011
Ian Schofield
Please Login to read the full article.
14 September 2011
Ian Schofield
Please Login to read the full article.
RELATED CONTENT
NEWS
- Servier's Protelos and Osseor are still important despite VTE and skin concerns, says EMA
- EMA reviews CV risk in NSAIDs and cancer risk in Protelos; concludes ARB review
- Iron chelator, prostate cancer conundrum on deck for ODAC
- France votes for more regulatory transparency, tighter safety monitoring and tougher promotion controls
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
